Category: Czech Republic

  • Havel & Partners Advises Lead Ventures on CloudTalk Investment

    Havel & Partners has advised Lead Ventures on co-leading a EUR 26 million investment round for CouldTalk. Prielomek & Partners reportedly advised CloudTalk.

    Lead Ventures is a Hungarian venture capital and private equity firm. It invested in CouldTalk through the Enter Tomorrow Kockzzati Tokealap fund.

    CloudTalk is a Slovak start-up active in the field of cloud-based solutions for call centers.

    According to Havel & Partners, “Lead Ventures was one of the two lead investors in the Series B investment round for a total of EUR 26 million. A total of six investors participated in the investment.”

    The Havel & Partners team included Partner Ondrej Majer, Senior Associates Peter Kosecky, Robert Gasparovic, and Sona Karbanova, Associates Adam Klizan, Milan Cernaj, Adam Samuel, and Ema Cerna, and Junior Associates Simon Gregus and Gabriel Kulik.

  • Michal Sylla Makes Associate Partner at PRK Partners in Prague

    Michal Sylla has been appointed to an Associate Partner position with PRK Partners in Prague.

    Specializing in dispute resolution, general corporate law, and banking and finance, Sylla joined PRK Partners as an Associate back in 2009. He became an Attorney at Law in 2012 and serves as the Czech Bar Association’s representative in the College of Experts on the Execution of Judgments of the European Court of Human Rights.

    We cordially congratulate Michal and are delighted that he will continue to help expand our litigation practice,” PRK Partners announced. “We wish him every success in his new position!”

  • Shortage of Critical Medicines: is a European Solution Available?

    There has been much discussion about protracted shortages of critical medicines in the Czech Republic over the last couple of months. Many national measures have been adopted. At the European Union level,the Voluntary Solidarity Mechanism for medicines has been put in place.

    This mechanism allows EU Member States to alert their peers about a critical national shortage of a certain medicine. Another Member State may help by redistributing its own medicinal stocks. The European pharmaceutical reform also addresses the composition of the European list of critical medicines.

    A new Critical Medicines Alliance should launch in the coming weeks. The Alliance will focus on establishing common rules for public procurements on the production and distribution of critical medicines, setting up a common strategy to tackle shortages of critical medicines and creating enough stocks. The Alliance’s aim is to strengthen the ability of EU Member States to produce their own critical medicines “domestically” and foster international cooperation on the production and distribution of critical medicines.  

    By Vladena Svobodova, Senior Associate, JSK, PONTES

  • CEE Attorneys Advises on Sale of Webscope to Mibcon Group

    CEE Attorneys has advised Webscope shareholder Jan Vorcak on the sale of the company to the Mibcon Group.

    Webscope is a software development firm that specializes in online and mobile app development, product design, code migration, and other services.

    The Mibcon Group describes itself as uniting companies operating in the field of information technology and offering “a wide range of activities, consulting services, and technologies.” The group operates in the Czech Republic and Slovakia.

    The CEE Attorneys team included Partner Lukas Petr and Senior Associates Veronika Fabian and Jakub Chvatal.

  • PRK Partners Advises Affimed on Divestment of AbCheck

    PRK Partners has advised Affimed on its successful divestment of AbCheck to Flagship Pioneering company Ampersand Biomedicines.

    Affimed is a clinical-stage immuno-oncology company.

    AbCheck is a Czech biotechnology company focusing on the discovery and development of human therapeutic antibodies.

    According to PRK Partners, “through the transaction, AbCheck became a wholly-owned subsidiary of Ampersand Biomedicines, a Flagship Pioneering company.”

    The PRK Partners team included Partner Monika Maskova and Co-Head of Corporate and M&A Milan Sivy.

    PRK Partners did not respond to our inquiry on the matter.

  • New Competition Tool and Call-In Power for Mergers in Czechia?

    The Czech Competition Authority (CCA) recently announced that it prepared a proposal to update the Czech Competition Act (the “Act”). While at present the proposal is just a set of ideas, it indicates how Czech competition enforcement may evolve in the years to come. Crucially, the CCA suggests deploying a “new competition tool” that will allow it to intervene even without proof of anticompetitive agreements or abuse of dominance. In addition, it wants to have call-in powers for under-threshold mergers.

    The proposal represents a collection of ideas that may initiate a formal legislative process. Currently, the CCA has not provided further details beyond a press release. Nevertheless, the release already provides insights into the CCA’s approach to enforcement for the upcoming years, clearly indicating a proactive stance. It should be recalled that the CCA has already been enforcing the act on significant market power and unfair trade practices (“UTP”) and holds authority for overseeing public procurement. If these ideas find their way into law, the CCA would arguably be one of the most powerful authorities within the EU, measured by the range of enforcement tools.

    New competition tool

    Currently, the CCA has the usual range of enforcement tools at its disposal. It can investigate anticompetitive agreements and abuse of dominance. It can also review mergers if they exceed standard turnover thresholds. Moreover, the CCA can run sectoral investigations to monitor markets, but cannot currently impose remedies without initiating a formal investigation of an anticompetitive agreement or an abuse of dominance. This is exactly where the CCA believes it needs a little more power.

    According to the proposal, after running a sectoral investigation and finding that competition in the market is not going well, the CCA could impose corrective measures on market participants. Even if the participants have not committed an antitrust offence, the CCA could require them to:

    • notify concentrations below notification thresholds;
    • adhere to transparency and non-discriminatory standards;
    • provide access to infrastructure and networks;
    • deal with other parties and modify business contracts;
    • publish information or provide data to competitors;
    • create separate business and accounting units; or
    • divest part of a business.

    While the CCA notes that the last option would be used only in extreme cases, it is nonetheless alarming and may affect investors’ willingness to enter the Czech market. It is relevant especially in industries mentioned by the CCA as prone to structural distortion, such as digital and other oligopolistic markets (energy and telecommunications markets may come to mind).

    Call-in powers for mergers

    In addition to the new competition tool, the CCA is apparently proposing a general call-in model. It would technically allow the CCA to require any transaction with a link to the Czech market to be notified. The power could work retroactively, so the CCA could even review closed deals.

    Currently, Czech notification criteria are based on usual turnover thresholds requiring the target or the parents of a joint venture to generate significant business in the Czech market. While transactions relating to Czech targets may already be called in by the Czech Ministry of Industry and Trade under the local FDI screening regime, it is confined to narrowly defined concerns about national security. If the CCA could also call in mergers affecting the competitive landscape, many more transactions could be under threat of reversal.

    Other proposed tools

    The proposal does not stop at the new competition tool and call-ins. The CCA also wants to be able to conduct dawn raids without needing to establish a reasonable suspicion of an antitrust infringement. In other words, it asks to be allowed to perform random and “preventive” inspections. Presently, the primary safeguard ensuring that dawn raids are used judiciously is the CCA’s obligation to possess sufficient suspicion. It is hard not to see that such a power could easily end up being used to “bully” competitors without effective judicial supervision.

    Finally, the CCA is also seeking to introduce fines for natural persons participating in anticompetitive conduct, typically the managers of investigated companies. As experience from other jurisdictions has shown, managers’ liability for a company’s infringement may be an important issue for clients when contemplating an investment in a local target.

    Conclusion

    The CCA’s extensive proposal marks the initial stage of a process with an uncertain outcome. Hopefully, we will see a discussion involving all stakeholders before the proposal evolves into a bill for consideration in a parliamentary session. Nevertheless, we may be at the dawn of the most important update to Czech competition law in the last 20 years.

    By Jan Kupcik, Attoreny at Law, Schoenherr

  • KSB Advises J&T Group on Sale of FVE Holding

    Kocian Solc Balastik has advised the J&T Group on its sale of FVE Holding to the EPH Group.

    The EPH Group is a Czech Republic-based company currently investing mainly in the energy sector in Europe, founded in 2009.

    FVE Holding specializes in household PV installations.

    According to the firm, the transaction was approved by the Czech Competition Authority in the second half of December and was completed before the end of the year.

    The KSB team included Partner Martin Krejci and Lawyer Jana Guricova.

    KSB did not respond to our inquiry on the matter.

  • KSB Advises Nemomax Growth Fund on EU Growth Prospectus

    Kocian Solc Balastik has advised real estate investment fund Nemomax on its first EU growth prospectus.

    According to KSB, “with fund capital of almost  CZK 1 billion, the investment fund focuses on investments in real estate projects in the Czech Republic, mainly in the residential housing sector, and is managed by Avant, a leading Czech investment company. The issuer will use the issue to finance its acquisition and development activities.”

    Recent Nemomax projects include VIVA Lipno (apartment houses on the banks of Lipno Lake), VIVA Vrchlabi (58 apartment units in the city of Vrchlabí), and family houses in Cimice and Bakovo.

    The KSB team included Partners Vlastimil Pihera and Josef Kriz.

  • PRK Partners Advises Thomayer University Hospital on Gender Equality Plan

    PRK Partners has advised the Thomayer University Hospital in Prague on the development of its gender equality plan.

    According to Jitka Soukupova, Deputy Director for Science, Research, Teaching, and International Affairs at TUH, by “introducing the GEP the hospital has reaffirmed its awareness and responsibility regarding gender equality as one of the fundamental social values, which has also manifested itself in the form of obtaining grants and other support from public sources.”

    The PRK Partners team included Partner Monika Maskova and Senior Attorney Jarmila Hanzalova.

  • Havel & Partners and Novalia Advise on Luigi’s Box Acquisition of Persoo

    Havel & Partners has advised Luigi’s Box on the acquisition of Persoo. Novalia advised Persoo.

    Luigi’s Box is a Slovak technology start-up company specializing in personalized search and product recommendation in e-shops. Persoo is a Czech start-up company operating in the same field.

    The Havel & Partners team included Partner Jaroslav Baier, Managing Associate Josef Bouchal, Associate Kristina Saktorova, and Junior Associate Robert Kosala.

    The Novalia team included Partner Jakub Cisar and Associate Tomas Bachtik.